Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?

por Haist, Maximilian, Stege, Henner, Kuske, Michael, Bauer, Julia, Klumpp, Annika, Grabbe, Stephan, Bros, Matthias
Publicado 2023

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis

por Klumpp, Annika, Luessi, Felix, Engel, Sinah, Weidenthaler-Barth, Beate, Becker, Detlef, Grabbe, Stephan, Schepler, Hadrian
Publicado 2022